跳至主要内容
临床试验/CTRI/2020/05/025281
CTRI/2020/05/025281尚未招募未知

A double blind randomized placebo controlled trial comparing genotype guided standard dosing with conventional dose escalation strategy of azathioprine in patients with ulcerative colitis.

Mukesh Kumar Ranjan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Confirmed cases of ulcerative colitis.
  • 1)Age 18-80 years.
  • 2)Willing to give informed consent.
  • 3)Ulcerative colitis patients who are steroid dependent.
  • 4)Ulcerative colitis patients who are steroid refractory.
  • 5)Patients with acute severe ulcerative colitis (ASUC) after complete response to initial systemic steroid therapy.

排除标准

  • 1)Severe cardiac, hepatic and/or renal insufficiency.
  • 2)Active tuberculosis.
  • 3)History of malignancy in last three years.
  • 4)Active viral hepatitis.
  • 5)Comorbidity such as bacterial or viral infection that has not been controlled effectively.
  • 6)Pregnancy.
  • 7)HIV infection.
  • 8)Patients not willing to give consent.
  • 9)Patients with homozygous NUDT 15 and TPMT variant polymorphism.

研究者

发起方
Mukesh Kumar Ranjan

相似试验